Identification of a novel locus on chromosome 2q13, which predisposes to clinical vertebral fractures independently of bone density
Authors
Nerea Alonso
Karol Estrada
Omar M. E. Albagha
Lizbeth Herrera
Sjur Reppe
Ole K. Olstad
Kaare M. Gautvik
Niamh M. Ryan
Kathryn L. Evans
Carrie M. Nielson
Yi-Hsiang Hsu
Douglas P. Kiel
George Markozannes
Evangelia E. Ntzani
Evangelos Evangelou
Bjarke Feenstra
Xueping Liu
Mads Melbye
Laura Masi
Maria Luisa Brandi
Philip Riches
Anna Daroszewska
Jose manuel Olmos
Carmen Valero
Jesus Castillo
Jose A. Riancho
Lise B. Husted
Bente L. Langdahl
Matthew A. Brown
Emma L. Duncan
Stephen Kaptoge
Kay-Tee Khaw
Ricardo Usategui-Martin
Javier Del Pino-Montes
Rogelio Gonzalez-Sarmiento
Joshua R. Lewis, Edith Cowan UniversityFollow
Richard L. Prince
Patrizia D'Amelio
Natalia Garcia-Giralt
Xavier Nogues
Simona Mencej-Bedrac
Janja Marc
Orit Wolstein
John A. Eisman
Ling Oei
Carolina Medina-Gomez
Katharina E. Schraut
Pau Navarro
James F. Wilson
Gail Davies
John Starr
Ian Deary
Toshiko Tanaka
Luigi Ferrucci
Fernando Gianfrancesco
Luigi Gennari
Gavin Lucas
Roberto Elosua
Andre G. Uitterlinden
Fernando Rivadeneira
Stuart H. Ralston
Document Type
Journal Article
Publication Title
Annals of the Rheumatic Diseases
Publisher
BMJ Publishing Group Ltd
School
School of Medical and Health Sciences
RAS ID
25742
Abstract
Objectives To identify genetic determinants of susceptibility to clinical vertebral fractures, which is an important complication of osteoporosis.
Methods Here we conduct a genome-wide association study in 1553 postmenopausal women with clinical vertebral fractures and 4340 controls, with a two-stage replication involving 1028 cases and 3762 controls. Potentially causal variants were identified using expression quantitative trait loci (eQTL) data from transiliac bone biopsies and bioinformatic studies.
Results A locus tagged by rs10190845 was identified on chromosome 2q13, which was significantly associated with clinical vertebral fracture (P=1.04×10−9) with a large effect size (OR 1.74, 95% CI 1.06 to 2.6). Bioinformatic analysis of this locus identified several potentially functional SNPs that are associated with expression of the positional candidate genes TTL (tubulin tyrosine ligase) and SLC20A1 (solute carrier family 20 member 1). Three other suggestive loci were identified on chromosomes 1p31, 11q12 and 15q11. All these loci were novel and had not previously been associated with bone mineral density or clinical fractures.
Conclusion We have identified a novel genetic variant that is associated with clinical vertebral fractures by mechanisms that are independent of BMD. Further studies are now in progress to validate this association and evaluate the underlying mechanism.
DOI
10.1136/annrheumdis-2017-212469
Access Rights
subscription content
Comments
Alonso, N., Estrada, K., Albagha, O. M., Herrera, L., Reppe, S., Olstad, O. K., ... & Hsu, Y. H. (2018). Identification of a novel locus on chromosome 2q13, which predisposes to clinical vertebral fractures independently of bone density. Annals of the Rheumatic Diseases, 77(3), 378-385.
10.1136/annrheumdis-2017-212469